Senores PharmaceuticalsMarch 28, 2025

FDA 483 - Senores Pharmaceuticals - March 28, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Senores Pharmaceuticals

Record Details

Senores Pharmaceuticals in Hoschton, GA, was cited for significant delays in submitting both quarterly and annual periodic adverse drug experience reports (PADERs) for multiple approved drugs. The inspection, conducted from March 25-28, 2025, revealed numerous instances where these critical safety reports were submitted well past their regulatory deadlines, indicating a systemic issue with postmarketing surveillance compliance.

Company: Senores Pharmaceuticals
Inspection Date: March 28, 2025
Product Type: Drugs
Office: Atlanta District Office
Person: Koffi A. Amegadje (issuing_officer)

Open in Dashboard

ID · 434177cd-583d-48a7-b9aa-4515358d8665